Lumason

(Sulfur hexafluoride lipid microsphere)

Lumason

Drug updated on 11/10/2023

Dosage FormInjection (intravenous: lipid-type A/ sulfur hexafluoride (25 mg/60.7 mg))
Drug ClassUltrasound contrast agents
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • Echocardiography to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border in adult and pediatric patients with suboptimal echocardiograms.
  • Ultrasonography of the liver for characterization of focal liver lesions in adult and pediatric patients.
  • Ultrasonography of the urinary tract for the evaluation of suspected or known vesicoureteral reflux in pediatric patients.